The therapeutic potential of bone marrow-derived stromal cells

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2683-2687

  Mezey, Eva ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

bone marrow stromal cells; immune regulation; tissue repair

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOKINE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOCOMPETENT CELL; MACROPHAGE; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REGULATORY T LYMPHOCYTE; STEM CELL RESEARCH; T LYMPHOCYTE;

ADULT STEM CELLS; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; STROMAL CELLS; TISSUE THERAPY;

EID: 80053176419     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23216     Document Type: Article

References (43)

1. Aggarwal S, Pittenger MF,. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
2. Augello A, Kurth TB, De Bari C,. 2010. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20: 121-133.
3. Barker N, Bartfeld S, Clevers H,. 2010. Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell stem cell 7: 656-670.
4. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R,. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48. (Pubitemid 34059216)
5. Bianco P, Robey PG, Saggio I, Riminucci M,. 2010. " Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther 21: 1057-1066.
6. Bianco P, Robey PG, Simmons PJ,. 2008. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell stem cell 2: 313-319. (Pubitemid 351467394)
7. Caplan AI,. 2009. Why are MSCs therapeutic? New data: new insight. J Pathol 217: 318-324.
8. Chen L, Tredget EE, Wu PY, Wu Y,. 2008. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 3: e1886.
9. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG,. 2006. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198: 54-64. (Pubitemid 43243744)
10. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR,. 2008. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. American journal of physiology. Cell Physiol 294: C675-82. (Pubitemid 351468685)
11. da Silva Meirelles L, Caplan AI, Nardi NB,. 2008. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299.
12. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM,. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843. (Pubitemid 34534559)
13. Feng J, Mantesso A, Sharpe PT,. 2010. Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 10: 1441-1451.
14. Gieseke F, Bohringer J, Bussolari R, Dominici M, Handgretinger R, Muller I,. 2010. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116: 3770-3779.
15. Granero-Molto F, Weis JA, Longobardi L, Spagnoli A,. 2008. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 8: 255-268. (Pubitemid 351428415)
16. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE,. 2006. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem cells 24: 1030-1041. (Pubitemid 44464736)
17. Jopling C, Boue S, Izpisua Belmonte JC,. 2011. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 12: 79-89.
18. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE,. 2004. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685. (Pubitemid 38387752)
19. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA,. 2010. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem cells 28: 2229-2238.
20. Le Blanc K,. 2006. Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy 8: 559-561. (Pubitemid 44869856)
21. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ,. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell stem cell 5: 54-63.
22. Medawar P,. 1969. The future of transplantation biology and medicine. Transplant Proc 1: 666-669.
23. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D,. 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621. (Pubitemid 38745993)
24. Mezey E,. 2011. Adult stem cell plasticity revisited. In:, Phinney DG, editor. Adult stem cells. Springer New York, Dordrecht, Heidelberg, London: Humana Press. pp 113-134.
25. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ,. 2005. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. USA 102: 18171-18176. (Pubitemid 41798520)
26. Nasef A, Ashammakhi N, Fouillard L,. 2008. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen Med 3: 531-546.
27. Nauta AJ, Fibbe WE,. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506. (Pubitemid 350159613)
28. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, Hodges MG, Jelinek I, Madala S, Karpati S, Mezey E,. 2010. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 107: 5652-5657.
29. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E,. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
30. Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A,. 2009. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8: 110-123.
31. Ogawa M, Larue AC, Watson PM, Watson DK,. 2010. Hematopoietic stem cell origin of connective tissues. Exp Hematol 38: 540-547.
32. Phinney DG, Prockop DJ,. 2007. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-Current views. Stem Cells 25: 2896-2902. (Pubitemid 350127874)
33. Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, Ottonello L, Pistoia V,. 2008. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem cells 26: 151-162.
34. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL,. 2004. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298. (Pubitemid 38372789)
35. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P,. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336. (Pubitemid 47592917)
36. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F,. 2008. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem cells 26: 212-222.
37. Sioud M,. 2011. New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins. Scand J Immunol 73: 79-84.
38. Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F,. 2008. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 15: 730-738. (Pubitemid 351627356)
39. Sugimoto K, Gordon SP, Meyerowitz EM,. 2011. Regeneration in plants and animals: dedifferentiation, transdifferentiation, or just differentiation? Trends Cell Biol 21: 212-218.
40. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB,. 2008. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem cells 26: 99-107.
41. Uccelli A, Moretta L, Pistoia V,. 2008. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
42. Wu Y, Chen L, Scott PG, Tredget EE,. 2007. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem cells 25: 2648-2659. (Pubitemid 47582758)
43. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I,. 2004. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104: 2643-2645. (Pubitemid 39434942)